ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr

218 views
October 11, 2024

Chapters

LAURA Trial Data for Stage III & CNS Progression

00:00

MARIPOSA Trial Updates & Combating CNS Progression

04:29

Resistance Mechanisms in MARIPOSA & SKIPPER Trial

07:18

PAPILLON & RESILIENT Trials for Exon 20 Insertions

10:36

Immunotherapy Approaches in EGFR-Mutant Population

13:59

Key Takeaways from ESMO 2024 on EGFR-mutant NSCLC

15:47

Comments 0
Login to view comments. Click here to Login